Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia.
about
Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy.Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a.
P2860
Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Minimal hepatic glucose-6-phos ...... cogen storage disease type Ia.
@ast
Minimal hepatic glucose-6-phos ...... cogen storage disease type Ia.
@en
type
label
Minimal hepatic glucose-6-phos ...... cogen storage disease type Ia.
@ast
Minimal hepatic glucose-6-phos ...... cogen storage disease type Ia.
@en
prefLabel
Minimal hepatic glucose-6-phos ...... cogen storage disease type Ia.
@ast
Minimal hepatic glucose-6-phos ...... cogen storage disease type Ia.
@en
P2093
P2860
P1476
Minimal hepatic glucose-6-phos ...... ycogen storage disease type Ia
@en
P2093
Chi-Jiunn Pan
Goo-Young Kim
Janice Y Chou
Young Mok Lee
P2860
P356
10.1016/J.YMGMR.2015.03.001
P577
2015-03-13T00:00:00Z